E
Aspira Women's Health Inc.
AWH
$0.1868
$0.01538.92%
E
Sell
5/14/2024Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D- on 5/14/2024 due to a decline in the volatility index, growth index and total return index.
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D- on 5/14/2024 due to a decline in the volatility index, growth index and total return index.
D
Sell
4/29/2024Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
Aspira Women's Health Inc. (AWH) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
E
Sell
4/12/2024Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
D
Sell
4/1/2024Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D- from E+ on 4/1/2024 due to an increase in the volatility index.
Aspira Women's Health Inc. (AWH) was upgraded to D- from E+ on 4/1/2024 due to an increase in the volatility index.
E
Sell
3/14/2024Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D- on 3/14/2024 due to a decline in the volatility index.
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D- on 3/14/2024 due to a decline in the volatility index.
D
Sell
2/26/2024Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D- from E+ on 2/26/2024 due to an increase in the valuation index.
Aspira Women's Health Inc. (AWH) was upgraded to D- from E+ on 2/26/2024 due to an increase in the valuation index.
E
Sell
3/14/2023Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D on 03/14/2023.
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D from E+ on 02/09/2023.
Aspira Women's Health Inc. (AWH) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index, solvency index and volatility index. Debt to equity increased from 0.22 to 0.25, and the quick ratio declined from 3.08 to 2.98.
Aspira Women's Health Inc. (AWH) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index, solvency index and volatility index. Debt to equity increased from 0.22 to 0.25, and the quick ratio declined from 3.08 to 2.98.
D
Sell
5/31/2022Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index.
Aspira Women's Health Inc. (AWH) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index.
D
Sell
5/13/2022Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.12 to 0.16, and the quick ratio declined from 4.87 to 4.62.
Aspira Women's Health Inc. (AWH) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.12 to 0.16, and the quick ratio declined from 4.87 to 4.62.
D
Sell
5/5/2022Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
Aspira Women's Health Inc. (AWH) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to D- from D on 4/20/2022 due to a major decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.08 to 0.12, and the quick ratio declined from 7.17 to 4.87.
Aspira Women's Health Inc. (AWH) was downgraded to D- from D on 4/20/2022 due to a major decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.08 to 0.12, and the quick ratio declined from 7.17 to 4.87.
D
Sell
11/11/2021Upgraded
Aspira Women's Health Inc. (AWH) was upgraded to D from D- on 11/11/2021.
Aspira Women's Health Inc. (AWH) was upgraded to D from D- on 11/11/2021.
D
Sell
11/8/2021Downgrade
Aspira Women's Health Inc. (AWH) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the growth index. EBIT declined 37.14% from -$5.89M to -$8.07M, operating cash flow declined 23.5% from -$5.26M to -$6.49M, and earnings per share declined from -$0.0545 to -$0.0632.
Aspira Women's Health Inc. (AWH) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the growth index. EBIT declined 37.14% from -$5.89M to -$8.07M, operating cash flow declined 23.5% from -$5.26M to -$6.49M, and earnings per share declined from -$0.0545 to -$0.0632.
D
Sell
5/1/2020Upgraded
Vermillion, Inc. (VRML) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index.
Vermillion, Inc. (VRML) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index.
D
Sell
1/16/2020Upgraded
Vermillion, Inc. (VRML) was upgraded to D- from E+ on 1/16/2020 due to an increase in the total return index and volatility index.
Vermillion, Inc. (VRML) was upgraded to D- from E+ on 1/16/2020 due to an increase in the total return index and volatility index.
E
Sell
12/23/2019Downgrade
Vermillion, Inc. (VRML) was downgraded to E+ from D- on 12/23/2019 due to a decline in the growth index and volatility index.
Vermillion, Inc. (VRML) was downgraded to E+ from D- on 12/23/2019 due to a decline in the growth index and volatility index.
D
Sell
2/15/2019Upgraded
Vermillion, Inc. (VRML) was upgraded to D- from E+ on 2/15/2019 due to an increase in the total return index and volatility index.
Vermillion, Inc. (VRML) was upgraded to D- from E+ on 2/15/2019 due to an increase in the total return index and volatility index.
E
Sell
1/18/2019Downgrade
Vermillion, Inc. (VRML) was downgraded to E+ from D- on 1/18/2019 due to a decline in the valuation index, total return index and volatility index.
Vermillion, Inc. (VRML) was downgraded to E+ from D- on 1/18/2019 due to a decline in the valuation index, total return index and volatility index.
D
Sell
8/14/2018Upgraded
Vermillion, Inc. (VRML) was upgraded to D- from E+ on 8/14/2018 due to a noticeable increase in the solvency index, valuation index and efficiency index. Total capital increased 377.16% from $2.86M to $13.64M, the quick ratio increased from 1.39 to 5.57, and debt to equity declined from 1.31 to 0.13.
Vermillion, Inc. (VRML) was upgraded to D- from E+ on 8/14/2018 due to a noticeable increase in the solvency index, valuation index and efficiency index. Total capital increased 377.16% from $2.86M to $13.64M, the quick ratio increased from 1.39 to 5.57, and debt to equity declined from 1.31 to 0.13.
E
Sell
7/10/2018Downgrade
Vermillion, Inc. (VRML) was downgraded to E+ from D- on 7/10/2018 due to a noticeable decline in the solvency index, total return index and valuation index. Debt to equity increased from 0.49 to 1.31, and the quick ratio declined from 2.2 to 1.39.
Vermillion, Inc. (VRML) was downgraded to E+ from D- on 7/10/2018 due to a noticeable decline in the solvency index, total return index and valuation index. Debt to equity increased from 0.49 to 1.31, and the quick ratio declined from 2.2 to 1.39.
D
Sell
3/11/2016Downgrade
Vermillion, Inc. (VRML) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
Vermillion, Inc. (VRML) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
NASDAQ
03/06/2025 4:00PM Eastern
Quotes delayed
